Transcode Therapeutics Inc (RNAZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 4,561 | 4,221 | 3,171 | 5,092 | 2,165 |
| Operating Income | -4,561 | -4,221 | -3,171 | -5,092 | -2,165 |
| Interest Expense | 6 | 0 | 0 | 2 | 11 |
| Other Income | -289 | -55 | -8,914 | -822 | -145 |
| Pre-tax Income | -4,856 | -4,277 | -12,085 | -5,916 | -2,321 |
| Net Income Continuous | -4,856 | -4,277 | -12,085 | -5,916 | -2,321 |
| Net Income | $-4,856 | $-4,277 | $-12,085 | $-5,916 | $-2,321 |
| EPS Basic Total Ops | -5.82 | -5.13 | -70.31 | 103.88 | -146.06 |
| EPS Basic Continuous Ops | -5.82 | -5.13 | -70.19 | 106.39 | -146.06 |
| EPS Diluted Total Ops | -5.82 | -5.13 | -70.31 | 103.88 | -146.06 |
| EPS Diluted Continuous Ops | -5.82 | -5.13 | -70.19 | 106.39 | -146.06 |
| EPS Diluted Before Non-Recurring Items | N/A | -4.94 | -16.81 | N/A | -147.91 |
| EBITDA(a) | $-4,556 | $-4,208 | $-3,120 | $-4,970 | $-2,038 |